I am delighted to announce that as of this week Dr. Lyle Skains joins us in FMC, Department of Communication & Journalism, as a Senior Lecturer in Health & Science Communication. Lyle researches and teaches Creative Digital Writing and Science Communication, conducting practice-based research into writing, reading/playing, publishing digital and transmedia narratives, and how these can be used for health and science communication. Her recent digital fiction includes No World 4 Tomorrow for the You & CO2 project, and Only, Always, Never for the Infectious Storytelling project; both works were designed to effect social change. She is the founder of Wonderbox Publishing, which publishes speculative digital fiction, aiming to explore innovations in digital and online publishing and creativity. Her digital fiction can be found at lyleskains.com; articles in Convergence, Digital Creativity, and Computers and Composition; and books with Cambridge UP (Digital Authorship), forthcoming Emerald (interdisciplinary scicomm) and Bloomsbury (convergent evolution of mainstream digital fiction).
Dr. Skains was appointed under the BU Academic Targeted Research Scheme and will be collaborating with colleagues in the department, faculty, university and beyond to support the further development of our innovative and world-leading scholarship in the areas of Health and Science Communication. You can drop her a line to set up a virtual coffee lskains@bournemouth.ac.uk.













BU academic publishes in online newspaper in Nepal
Final day of the ESRC Festival of Social Science
Using Art to enhance Research
Register now to attend the 17th Annual Postgraduate Research Conference – Wednesday 3 December 2025
ECR Funding Open Call: Research Culture & Community Grant – Application Deadline Friday 12 December
MSCA Postdoctoral Fellowships 2025 Call
ERC Advanced Grant 2025 Webinar
Horizon Europe Work Programme 2025 Published
Horizon Europe 2025 Work Programme pre-Published
Update on UKRO services
European research project exploring use of ‘virtual twins’ to better manage metabolic associated fatty liver disease